In the Original Investigation titled “Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma,”1 published September 27, 2021, there were errors in the number of patients included at several stages of the flow diagram in Figure 1. This article has been corrected.1
Errors in Figure 1. JAMA Netw Open. 2022;5(1):e2148091. doi:10.1001/jamanetworkopen.2021.48091
Customize your JAMA Network experience by selecting one or more topics from the list below.